![Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Fabrice-Kwiatkowski/publication/282813204/figure/fig5/AS:667069091680256@1536053073041/TTF-in-the-general-population-a-and-as-a-function-of-dose-adaptation-b-Inclusion_Q320.jpg)
Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram
![Figure 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Figure 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/4-Figure1-1.png)
Figure 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
![Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Fabrice-Kwiatkowski/publication/282813204/figure/tbl4/AS:667069091680259@1536053073145/Multivariate-analysis-to-predict-TTF_Q320.jpg)
Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram
![Changes of serum tumor marker levels (CA125 and CA19-9) during therapy:... | Download Scientific Diagram Changes of serum tumor marker levels (CA125 and CA19-9) during therapy:... | Download Scientific Diagram](https://www.researchgate.net/publication/329805960/figure/fig2/AS:705914768195585@1545314604492/Changes-of-serum-tumor-marker-levels-CA125-and-CA19-9-during-therapy-a-the-days-of.png)
Changes of serum tumor marker levels (CA125 and CA19-9) during therapy:... | Download Scientific Diagram
![PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a96fc01f495907ea18214fdc7db7ffd9b210d72c/2-TableI-1.png)
PDF] Application of biochemical markers CA 19-9, CEA and C-reactive protein in diagnosis of malicious and benign pancreatic tumors | Semantic Scholar
![Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram](https://www.researchgate.net/profile/Vincenzo-Cerullo/publication/42255556/figure/fig3/AS:277343659675652@1443135289838/Serum-tumor-markers-NSE-Ca-15-3-CEA-PSA-Ca-12-5-Ca-19-9-of-14-patients-were.png)
Serum tumor markers (NSE, Ca 15–3, CEA, PSA, Ca 12–5, Ca 19–9) of 14... | Download Scientific Diagram
![Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)
Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
![Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram Tumor markers CA15-3 (n = 31; a ) and CEA (n = 23; b ) in patients with... | Download Scientific Diagram](https://www.researchgate.net/profile/Fabrice-Kwiatkowski/publication/282813204/figure/fig4/AS:667069087481868@1536053072974/Tumor-markers-CA15-3-n-31-a-and-CEA-n-23-b-in-patients-with-abnormal-markers.png)